Slingshot members are tracking this event:

Novartis (NVS) Announces Top-Line Results from Phase III EXPAND Trial Evaluating BAF312 in Secondary Progressive Multiple Sclerosis

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks

Slingshot Insights Explained
Catalyst Date
Occurred on:
Sep 17, 2016
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Top-line Results, Phase Iii Expand Trial, Baf312, Secondary Progressive Multiple Sclerosis